All Stories

  1. Indications for Performing the APCA Test in Female Infertility
  2. TNFAIP3 Gene Polymorphisms and the Risk of Thrombocytopenia: A Cross‐Sectional Study in Iranian Population
  3. Investigating the predictive role of inflammatory indices in cancer metastasis
  4. Immune System‐Related Genetic Risk Factors for Inhibitory Antibody Development in Patients With Hemophilia: Reviewing an Old Problem From a New Perspective—A Narrative Review
  5. The role of platelets in the regulation of myeloid-derived suppressor cells in immune thrombocytopenia
  6. Assessment of rs1205 and rs1130864 Polymorphisms of C‐Reactive Protein Gene (CRP) and Serum CRP Levels in Immune Thrombocytopenia: A Case‐Control Study
  7. Update Prognostic Potency of Vascular Endothelial Growth Factor‐A in the Acute Lymphoblastic Leukemia Landscape: A Meta‐Analysis
  8. Missense and nonsense mutations and inhibitor development in patients with hemophilia A and B
  9. The Association of Serum Level of TGF‐β1 and Clinical Manifestations in Sickle Cell Anemia: A Case‐Control Study
  10. Impact of Genetic Polymorphisms on Treatment Outcomes of Proteasome Inhibitors and Immunomodulatory Drugs in Multiple Myeloma
  11. Evaluation of Complete Blood Count Parameters in Patients With Diabetes Mellitus: A Systematic Review
  12. The Association of Nasal and Blood Eosinophils with Serum IgE Level in Allergic Rhinitis and Asthma: A Case‐Control Study
  13. Evaluation of Pro‐BNP biomarker in heart failure patients and its relationship with complete blood count parameters: A case–control study
  14. DNA damage repair in megakaryopoiesis: molecular and clinical aspects
  15. Modification macrophage to foam cells in atherosclerosis disease: some factors stimulate or inhibit this process
  16. The need to establish and recognize the field of clinical laboratory science (CLS) as an essential field in advancing clinical goals
  17. The prognostic potential of long noncoding RNA XIST in cardiovascular diseases: a review
  18. A systematic review of second-generation FLT3 inhibitors for treatment of patients with relapsed/refractory acute myeloid leukemia
  19. Emerging Roles of HOTAIR LncRNA in the Pathogenesis and Prognosis of Cardiovascular Diseases
  20. Association of Free Radical Product and Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis
  21. lncRNA TUG1 as Potential Novel Biomarker for Prognosis of Cardiovascular Diseases
  22. rs1800890 Polymorphism of IL-10 and Susceptibility to Idiopathic Thrombocytopenic Purpura
  23. Regulation and Functions of α6-Integrin (CD49f) in Cancer Biology
  24. Biomarkers of endothelial dysfunction are associated with poor outcome in COVID‐19 patients: A systematic review and meta‐analysis
  25. Association of human papillomavirus with breast cancer: a new perspective on an old debate
  26. Application of Bayesian Decision Tree in Hematology Research: Differential Diagnosis of β-Thalassemia Trait from Iron Deficiency Anemia
  27. Aplastic anemia, cellular and molecular aspects
  28. Aspirin exacerbated respiratory disease (AERD): molecular and cellular diagnostic & prognostic approaches
  29. The effect of inflammatory factors and their inhibitors on the hematopoietic stem cells fate
  30. Platelets in In-stent Restenosis: From Fundamental Role to Possible Prognostic Application
  31. Chemo/radiotherapy-Induced Bone Marrow Niche Alterations
  32. The role of exogenous Fibrinogen in cardiac surgery: stop bleeding or induce cardiovascular disease
  33. Co-existence of mutations in myeloproliferative neoplasms and their clinical significance: a prognostic approach
  34. Prognostic role and therapeutic susceptibility of cathepsin in various types of solid tumor and leukemia: A systematic review
  35. T-Cell Molecular Modulation Responses in Atherosclerosis Anergy
  36. Epigenetic modifications and transcriptional networks in leukemic transformation of HSCs
  37. STAT5: From Pathogenesis Mechanism to Therapeutic Approach in Acute Leukemia
  38. Investigation of JAK2V617F Mutation Prevalence in Patients with Beta Thalassemia Major
  39. Cardiomyopathy in Thalassemia: Quick Review from Cellular Aspects to Diagnosis and Current Treatments
  40. Expression of Blood Cells Associated CD Markers and Cardiovascular Diseases: Clinical Applications in Prognosis
  41. Involvement of circulating inflammatory factors in prognosis and risk of cardiovascular disease
  42. Neutropenia and leukemia development: genetic risk factors and prognosis
  43. Immunomodulation in leukemia: cellular aspects of anti-leukemic properties
  44. CD markers variations in chronic lymphocytic leukemia: New insights into prognosis
  45. Involvement of Interferon‐γ + 874A/T Polymorphism in the Pathogenesis of and Therapeutic Response to Immune Thrombocytopenia
  46. Strategies to inhibit arsenic trioxide‐induced cardiotoxicity in acute promyelocytic leukemia
  47. Role of bone marrow adipocytes in leukemia and chemotherapy challenges
  48. T‐bet transcription factor in cardiovascular disease: Attenuation or inflammation factor?
  49. Endothelial Cells: From Dysfunction Mechanism to Pharmacological Effect in Cardiovascular Disease
  50. Protective role of heat shock transcription factor 1 in heart failure: A diagnostic approach
  51. Signaling-chemokine axis network in brain as a sanctuary site for metastasis
  52. Platelet Activation Polymorphisms in Ischemia
  53. Cellular expression of CD markers in immune thrombocytopenic purpura: implications for prognosis
  54. Role of chemokines in metastatic niche: new insights along with a diagnostic and prognostic approach
  55. Oxidative stress in normal hematopoietic stem cells and leukemia
  56. JAK2V617F allele burden: innovative concept in monitoring of myeloproliferative neoplasms
  57. Cardiovascular disease cause challenge in hematologic cancers
  58. Aberrant DNA Methylation in Chronic Myeloid Leukemia: Cell Fate Control, Prognosis, and Therapeutic Response
  59. How is the relationship between TWIST-1 and BCR-ABL1 gene expressions in chronic myeloid leukaemia patients?
  60. Antioxidant and hepatoprotective effects of Capparis spinosa L. fractions and Quercetin on tert-butyl hydroperoxide- induced acute liver damage in mice
  61. Association between gene polymorphisms and clinical features in idiopathic thrombocytopenic purpura patients
  62. BCR/ABL analysis in myelodysplastic syndromes
  63. Restoration of natural killer cell cytotoxicity in the suppressive tumor microenvironment: novel approaches to treat AML
  64. Evaluation of miR-21 and miR-150 expression in immune thrombocytopenic purpura pathogenesis: a case-control study
  65. Expression of CD markers' in immune thrombocytopenic purpura: prognostic approaches
  66. Sex chromosome changes in leukemia: cytogenetics and molecular aspects
  67. Optimizing peripheral blood stem cells transplantation outcome through amend relapse and graft failure: a review of current literature
  68. Association between beta globin haplotypes, HBBP1 and HMOX1 polymorphisms in relation to HbF among sickle cell anemia patients: a study in Southwest Iran
  69. tree-based methods for differential diagnosis of hematologic disorders
  70. An association study between CHEK2 gene mutations and susceptibility to breast cancer
  71. Prognostic significance of aberrant expression of CD markers in acute lymphoblastic leukemia
  72. Crosstalk between catecholamines and erythropoiesis
  73. The role and clinical implications of the endosteal niche and osteoblasts in regulating leukemia
  74. MicroRNAs as prognostic biomarker and relapse indicator in leukemia
  75. PD-1/PD-L1 as a prognostic factor in leukemia
  76. Estimation of diagnosis and prognosis in ET by assessment of CALR and JAK2V617F mutations and laboratory findings: a meta-analysis
  77. Association between microRNA-21, microRNA-150, and micro-RNA-451 expression and clinical outcome of patients with acute lymphoblastic leukemia
  78. Analysis of DNA methyltransferase 3A gene mutations in patients with Philadelphia-negative myeloproliferative neoplasms
  79. Role of oxidative stress in liver cancer
  80. Sequencing myeloproliferative leukemia exon 10 mutations in iranian patients with breakpoint cluster region-abelson murine leukemia viral oncogene homolog 1-negative myeloproliferative neoplasm
  81. Bone marrow blood vessels: normal and neoplastic niche
  82. High platelet count and high probability of CALR detection in myeloproliferative neoplasms
  83. Acute myeloid leukemia in the vascular niche
  84. Incidence of T315I mutation in BCR/ABL-positive CML and ALL patients
  85. Regulatory role of Megakaryocytes on Hematopoietic Stem Cells Quiescence by CXCL4/PF4 in Bone Marrow Niche
  86. Mesenchymal stem cells as a double-edged sword in suppression or progression of solid tumor cells
  87. Cytogenetic changes of mesenchymal stem cells in the neoplastic bone marrow niche in leukemia
  88. Bone marrow niche in immune thrombocytopenia: a focus on megakaryopoiesis
  89. Role of stem cell factor in the placental niche
  90. Significance of oncogenes and tumor suppressor genes in AML prognosis
  91. A cocktail of repurposed drugs for targeted therapy of glioblastoma
  92. Is Wilms’ tumor gene 1 a useful biomarker for detecting minimal residual disease in chronic myeloid leukemia (BCR-ABL1-p210-positive) patients?
  93. Evaluation of α-Globin Gene Mutations Among Different Ethnic Groups in Khuzestan Province, Southwest Iran
  94. Evaluation of microRNA-146a expression in acute lymphoblastic leukemia
  95. Stem Cell Therapy ‒ Approach for Multiple Sclerosis Treatment
  96. Is There a Relationship Between CXCR4 Gene Expression and Prognosis of Immune Thrombocytopenia in Children?
  97. Signaling and molecular basis of bone marrow niche angiogenesis in leukemia
  98. Coexistence of P190 BCR/ABL transcript and CALR 52-bp deletion in chronic myeloid leukemia blast crisis: a case report
  99. Hepatic metastatic niche: from normal to pre-metastatic and metastatic niche
  100. Prognostic value and clinical significance of TCR rearrangements for MRD monitoring in ALL patients
  101. Survivin and SIRT1: can be two prognostic factors in chronic myeloid leukemia?
  102. Wnt/β-catenin signaling in bone marrow niche
  103. Inhibition of Ras-mediated signaling pathways in CML stem cells
  104. Bone marrow niche in the myelodysplastic syndromes
  105. Central nervous system niche involvement in the leukemia
  106. MicroRNAs in erythropoiesis and red blood cell disorders
  107. Twist as a new prognostic marker in hematological malignancies
  108. The Influence of Polymorphisms in Disease Severity in β-Thalassemia
  109. The bone marrow metastasis niche in retinoblastoma
  110. Immunophenotype, microRNA expression and cytogenetic characterization of acute leukemias of ambiguous lineage
  111. Rare cytogenetic abnormalities and alteration of microRNAs in acute myeloid leukemia and response to therapy
  112. Regulatory effect of chemokines in bone marrow niche
  113. Targeting PI3K/AKT/mTOR network for treatment of leukemia
  114. The mechanistic role of epigenetic in multiple myeloma
  115. Molecular basis of chronic lymphocytic leukemia diagnosis and prognosis
  116. G-CSF induces up-regulation of CXCR4 expression in human hematopoietic stem cells by beta-adrenergic agonist
  117. A case of chronic lymphoblastic leukemia with an abnormal rare karyotype
  118. The role of Pax5 in leukemia: diagnosis and prognosis significance
  119. Hodgkin’s lymphoma after 2-month infliximab therapy: case report
  120. Minimal residual disease in acute lymphoblastic leukemia: optimal methods and clinical relevance, pitfalls and recent approaches
  121. BRAF mutation in hairy cell leukemia
  122. New insights in cellular and molecular aspects of BM niche in chronic myelogenous leukemia
  123. PCR Analysis of IgH and TCR-γ Gene Rearrangements as a Confirmatory Diagnostic Tool for Lymphoproliferative Disorders
  124. The role of notch signaling in bone marrow niche
  125. Induction of Fetal Hemoglobin as a Novel Therapeutic Strategy for β-Hemoglobinopathy
  126. Pattern of immunoglobulin and T-cell receptor-δ/γ gene rearrangements in Iranian children with B-precursor acute lymphoblastic leukemia
  127. Frequency of β-Thalassemia or β-Hemoglobinopathy Carriers Simultaneously Affected with α-Thalassemia in Iran
  128. Prooxidant-Antioxidant Balance and hs-CRP in Patients with β-Thalassemia Major
  129. The role of microRNAs in stemness of cancer stem cells
  130. Meta-analysis of Genetic Polymorphisms and Ophthalmologic Disease Risk in Asian Populations: a Case of DNA Repair XRCC1 Gene
  131. Bone marrow neoplastic niche in leukemia
  132. The roles of miR-146a in the differentiation of Jurkat T-lymphoblasts
  133. The Role of the Nervous System in Hematopoietic Stem Cell Mobilization
  134. Does DNA Methylation Plays a Critical Role in Osteoblastic Differentiation of Mesenchymal Stem Cells (MSCs)?
  135. Expressional Correlation of Human Epidermal Growth Factor Receptor 2, Estrogen/Progesterone Receptor and Protein 53 in Breast Cancer
  136. Evaluation of H3 Histone Methylation and Colony Formation in Erythroid Progenitors Treated with Thalidomide and Sodium Butyrate
  137. JAK2 V617F Mutation in Iranian Patients with Myeloproliferative Neoplasms: Clinical and Laboratory Findings
  138. Biology and Bioinformatics of Myeloma Cell
  139. The first report of homozygous May-Hegglin anomaly E1841K mutation